World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
23325
World Ranking
2111
National Ranking
1027

Phillip D. Markham publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Phillip D. Markham sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 143 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Phillip D. Markham D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Phillip D. Markham sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Phillip D. Markham is affiliated with Northrop Grumman in the United States. Their work is situated within this primary professional context.

There is no recorded information on recent papers, co-authors, publication venues, book publications, main or subfields of study, or main topics of work associated with Phillip D. Markham. The profile contains no details regarding published works or specific research contributions.

No awards or honors have been documented for Phillip D. Markham at this time.

The available data does not indicate any further professional or academic details such as research interests, collaborations, or scholarly output beyond the current affiliation.

Best Publications

  • Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS

    Robert C. Gallo;Syed Z. Salahuddin;Mikulas Popovic;Gene M. Shearer

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS

    Beatrice H. Hahn;George M. Shaw;Maria E. Taylor;Robert R. Redfield

  • Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma

    Barbara Ensoli;Rita Gendelman;Phillip Markham;Valeria Fiorelli

  • Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.

    L Resnick;F diMarzo-Veronese;J Schüpbach;W W Tourtellotte

  • HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS

    JE Groopman;SZ Salahuddin;MG Sarngadharan;PD Markham

  • Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

    S Z Salahuddin;P D Markham;F Wong-Staal;G Franchini

  • Human T lymphotropic virus type III infection of human alveolar macrophages.

    Syed Z. Salahuddin;Richard M. Rose;Jerome E. Groopman;Phillip D. Markham

  • The Acquired Immunodeficiency Syndrome: An Update

    Fauci As;Masur H;Gelmann Ep;Markham Pd

  • In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6).

    P Lusso;P D Markham;E Tschachler;F di Marzo Veronese

  • Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.

    Paolo Lusso;Barbara Ensoli;Phillip D. Markham;Dharam V. Ablashi

  • Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

    P. Lusso;F. Cocchi;C. Balotta;P. D. Markham

  • ALVAC-SIV-gag-pol-env-Based Vaccination and Macaque Major Histocompatibility Complex Class I (A*01) Delay Simian Immunodeficiency Virus SIVmac-Induced Immunodeficiency

    R. Pal;D. Venzon;N. L. Letvin;S. Santra

  • Genomic diversity of human T-lymphotropic virus type III (HTLV-III).

    F Wong-Staal;GM Shaw;BH Hahn;SZ Salahuddin

  • HTLV-III in symptom-free seronegative persons.

    S.Zaki Salahuddin;PhillipD. Markham;RobertR. Redfield;M. Essex

  • Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.

    Marjorie Robert-Guroff;Mikulas Popovic;Suzanne Gartner;Phillip Markham

  • Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques.

    Igor M. Belyakov;Zdenek Hel;Brian Kelsall;Vladimir A. Kuznetsov

  • Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

    Felipe Samaniego;Phillip D. Markham;Rita Gendelman;Yoshiki Watanabe

  • Inhibition of HIV-1 Infection by the β-Chemokine MDC

    Ranajit Pal;Alfredo Garzino-Demo;Phillip D. Markham;Jennifer Burns

  • Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

    Samuel Broder;JerryM Collins;PhillipD Markham;RobertR Redfield

Frequent Co-Authors

Robert C. Gallo
Robert C. Gallo University of South Florida
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Ranajit Pal
Ranajit Pal Advanced Bioscience Laboratories (United States)
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Paolo Lusso
Paolo Lusso National Institutes of Health
Mikulas Popovic
Mikulas Popovic University of Maryland, Baltimore
Marvin S. Reitz
Marvin S. Reitz University of Maryland, Baltimore
Vaniambadi S. Kalyanaraman
Vaniambadi S. Kalyanaraman North Shore University Hospital
David C. Montefiori
David C. Montefiori Duke University
Barbara Ensoli
Barbara Ensoli Istituto Superiore di Sanità

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and healthcare, pursuing advanced nursing degrees often complements this field. Online options like pmhnp programs online with best clinical placement provide flexible pathways to specialize in psychiatric nursing while gaining hands-on experience through strong clinical affiliations.

Cost is a crucial factor when choosing a program. Many students seek out the cheapest psychiatric nurse practitioner programs to balance quality education with affordability, ensuring wider access to career advancement without sacrificing academic rigor.

Understanding compensation trends is important for career planning. Exploring the doctorate in nursing salary can help immunology-focused professionals compare earnings across regions and evaluate returns on further education investments.

Many registered nurses consider specialization through certifying exams. For example, enhancing skills by obtaining an acute care certification for fnp opens doors to acute care settings, blending advanced nursing practice with immunology knowledge to treat complex patient needs.

Best Scientists Citing Phillip D. Markham

Trending Scientists

Recently Published Articles